Trial intelligence / Profile preview

Dexmedetomidine for emergence agitation after cleft lip and palate surgery

ChiCTR-TRC-13003865Phase 4Completed

Sponsor
Hospital of Stomatology Wuhan University
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in orofacial cleft (OFC) (2 arms), sponsored by Hospital of Stomatology Wuhan University. Primary endpoints: Heart rate and Blood pressure. Started Jan 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

orofacial cleft (OFC)

Beyond the preview

Go deeper on ChiCTR-TRC-13003865.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003865.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call